E-MAIL   PASSWORD Forgot password?New user?
Allergy and Immunology

Targeting the Allergic Cascade: Current and Evolving Options?

Archived CME Activity

 
The prevalence of allergic rhinitis in the United States is estimated to be between 10% and 20% and has been increasing during the past several years. Antihistamines have been widely used to treat and revent symptoms associated with allergic rhinitis and are considered one of the mainstays of pharmacotherapy. New therapeutic options are on the horizon, and their place in the clinician’s armamentarium will need to be defined.

    Women's Health / Gynecology

    Also In Global Health News: Congo Security Warnings; Niger Food Crisis; Drug Cost In Developing Countries; Measles Vaccination In China
    Fri, 03 Sep 2010 06:00:00 PDT

    Cancer / Oncology

    Celsion Receives SBIR Grant To Expand Its Technology Platform
    Fri, 03 Sep 2010 05:00:00 PDT
    View more >>

    • Milestones in Medicine: Reviewing the Past, Present, and Future of Immunosuppression Therapy in Renal Transplantation

      Milestones in Medicine: Reviewing the Past, Present, and Future of Immunosuppression Therapy in Renal Trans...

      Allergic Rhinitis: Impact and Action Plan for the Use of OTC and Prescription Agents

      Allergic rhinitis is a common and increasingly prevalent disease worldwide, affecting at least 10-25% of the population. Although allergic rhinitis is not a life-threatening disease, it can have significant adverse effects on performance, mood, and s...